Autopsy report · NCT06225076

Efficacy of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke

“ethical issues”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Zeng Changhao

Sponsor type

University, hospital or other

Conditions

Bulbar Palsy

Interventions

Comprehensive rehabilitation; Stellate ganglion block; Lidocaine Hydrochloride

Participants

0

Sites

1

Countries

China

Trials that died the same way

• The Effect of ACT and Float REST on Burnout Syndrome.
  “Ethics Committee concerns.” (66% match in meaning)
• Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)
  “medical/ethical reasons” (57% match in meaning)
• Evidence-Based Osteopathy for Tension-Type Headache (EBOTTH)
  “Problems for satellite centers in obtaining ethical clearance.” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.